CASI Pharmaceuticals Ownership | Who Owns CASI Pharmaceuticals?
CASI Pharmaceuticals Ownership Summary
CASI Pharmaceuticals is owned by 11.14% institutional investors, and 88.86% retail investors. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.13% of its assets in CASI Pharmaceuticals shares.
CASI Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | CASI Pharmaceuticals | 11.14% | - | 88.86% |
| Sector | Healthcare Stocks | 47.25% | 8.01% | 44.75% |
| Industry | Biotech Stocks | 45.35% | 7.81% | 46.83% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Nasdaq Composite Index | 19.36K | 0.13% | - |
| NT Quality SCC US Fund - L | 1.93K | 0.01% | -180.00 |
| NT Quality Small Cap Core | 1.93K | 0.01% | -180.00 |
| JNL/DFA US Small Cap A | 1.67K | 0.01% | - |
| Dimensional US Small Cap CIT Class S | 1.03K | 0.01% | - |
| Dimensional US Sm Company EUR Acc | 306.00 | 0.00% | - |
| AZL® DFA US Small Cap | 142.00 | 0.00% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 06, 2022 | Huang James | Buy | $142.63K | |
| Aug 31, 2022 | Huang James | Buy | $1.50K | |
| Aug 24, 2022 | Huang James | Buy | $148.18K | |
| Aug 19, 2022 | Huang James | Buy | $139.99K | |
| Jun 15, 2022 | He Wei-Wu | Chairman and CEO | Buy | $159.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2022 Q3 | 4 | - |
| 2022 Q2 | 1 | - |
| 2021 Q4 | 2 | - |
| 2021 Q3 | 2 | - |
| 2021 Q2 | - | - |
CASI Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools